Lilly Just Opened Door to a GLP-1 Growth Boom in Markets
Eli Lilly unveiled a direct-to-employer program for Zepbound, aiming to accelerate GLP-1 adoption and expand market s...
Stay informed with the latest Ai Healthcare News. Discover how artificial intelligence is revolutionizing the healthcare industry.
4,881 articlesEli Lilly unveiled a direct-to-employer program for Zepbound, aiming to accelerate GLP-1 adoption and expand market s...
Reno has overtaken Las Vegas as the top destination for California homebuyers seeking affordability, driven by supply...
Geopolitical tensions are sparking volatility in the helium market. This report explains how a disruption in helium s...
Two AI powerhouses, two very different bets. This guide compares Nvidia and Palantir to help you decide which path fi...
As inflation cools and markets wobble, a quartet of monthly-pay ETFs now offers 6% to 9% yields. This article explain...
TSA workers in Atlanta push for a resolution to the DHS shutdown after more than a month without pay, highlighting pe...
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
RF Industries (RFIL) faces a mix of aerospace, medical, and data-communications demand in 2026. This guide breaks dow...
A new Redfin analysis using Federal Reserve data shows Americans aged 70-plus now hold a 26% share of U.S. real estat...
Income-focused investing is making waves in 2026. This high-yielding dividend beating ETF has shown resilience as bro...
A Boston federal judge blocks jr.’s plan to cut childhood vaccine guidance, halting the changes pending a full hearin...
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...